|Articles|February 1, 2010
- Pharmaceutical Executive-02-01-2010
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - February 2010
Shire’s Second Act
Advertisement
Articles in this issue
over 16 years ago
A Sturdy Frameworkover 16 years ago
Vaccines and Valueover 16 years ago
Tearing Up the Rule Bookover 16 years ago
Assets for AdvantageAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
2026 Pharm Exec Top 50 Companies
2
What Does the Operational Reality of Reshoring Actually Look Like?
3
AI at the FDA: Efficiency, Oversight, and Open Questions
4
FDA Grants Accelerated Approval to Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma
5